Abstract
Canine cutaneous and subcutaneous mast cell tumors (MCTs) have highly variable clinical presentation, often mimicking benign lesions. This retrospective case–control study aimed to identify triple‐phase computed tomography (CT) features that distinguish MCTs from benign lesions, with an emphasis on tumor size. Twenty‐three MCTs (10 large [≥3 cm]; 13 small [p = 0.025 and 0.034, respectively). Receiver operating characteristic curve analysis for discriminating small MCTs from benign lesions yielded optimal cutoff values of 68.7 Hounsfield units (HU) for the portal venous phase (area under the curve [AUC] = 0.88; sensitivity, 92%; specificity, 71%) and 74.7 HU for the equilibrium phase (AUC = 0.85; sensitivity, 92%; specificity, 57%). In conclusion, despite the limited sample size, these findings suggest that triple‐phase CT has clinical utility for differentiating MCTs from benign lesions. Qualitative patterns are particularly informative for large MCTs, whereas CT attenuation values in the portal venous and equilibrium phases may serve as objective adjunct indicators for identifying small MCTs that lack distinct morphological features.

This publication has 20 references indexed in Scilit: